Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Capital Employed: 2009-2025

Historic Return on Capital Employed for Aytu Biopharma (AYTU) over the last 14 years, with Sep 2025 value amounting to -0.14%.

  • Aytu Biopharma's Return on Capital Employed fell 10.00% to -0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.14%, marking a year-over-year decrease of 10.00%. This contributed to the annual value of -0.13% for FY2025, which is 10.00% down from last year.
  • Per Aytu Biopharma's latest filing, its Return on Capital Employed stood at -0.14% for Q3 2025, which was down 11.98% from -0.13% recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Return on Capital Employed registered a high of 0.02% during Q1 2024, and its lowest value of -1.23% during Q2 2022.
  • Over the past 3 years, Aytu Biopharma's median Return on Capital Employed value was -0.13% (recorded in 2025), while the average stood at -0.15%.
  • In the last 5 years, Aytu Biopharma's Return on Capital Employed plummeted by 86bps in 2022 and then surged by 100bps in 2023.
  • Quarterly analysis of 5 years shows Aytu Biopharma's Return on Capital Employed stood at -0.71% in 2021, then declined by 30bps to -1.01% in 2022, then spiked by 92bps to -0.09% in 2023, then dropped by 5bps to -0.14% in 2024, then dropped by 10bps to -0.14% in 2025.
  • Its last three reported values are -0.14% in Q3 2025, -0.13% for Q2 2025, and -0.06% during Q1 2025.